Is Enliven Therapeutics, Inc. technically bullish or bearish?

As of 26 September 2025, the technical trend for Enliven Therapeutics, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, supported by bearish MACD readings on both weekly and monthly time frames, and a mildly bearish signal from the daily moving averages. The Bollinger Bands indicate a sideways movement on the weekly chart and a bearish trend on the monthly chart. Additionally, the KST and OBV are both mildly bearish on a weekly basis, while the Dow Theory shows a mildly bearish stance on the weekly chart with no trend on the monthly.
In terms of performance, the stock has returned 5.54% over the past week, outperforming the S&P 500, which returned -0.31%. However, over the longer term, the stock has underperformed the S&P 500 with a year-to-date return of -11.07% compared to the S&P's 12.96%, and a one-year return of -17.04% versus 15.64% for the index.